CHARLES WYKOFF to Transcription Factors
This is a "connection" page, showing publications CHARLES WYKOFF has written about Transcription Factors.
Connection Strength
0.391
-
The HIF pathway: implications for patterns of gene expression in cancer. Novartis Found Symp. 2001; 240:212-25; discussion 225-31.
Score: 0.088
-
Hypoxia-inducible expression of tumor-associated carbonic anhydrases. Cancer Res. 2000 Dec 15; 60(24):7075-83.
Score: 0.087
-
Identification of novel hypoxia dependent and independent target genes of the von Hippel-Lindau (VHL) tumour suppressor by mRNA differential expression profiling. Oncogene. 2000 Dec 14; 19(54):6297-305.
Score: 0.087
-
Genetic analysis of the role of the asparaginyl hydroxylase factor inhibiting hypoxia-inducible factor (FIH) in regulating hypoxia-inducible factor (HIF) transcriptional target genes [corrected]. J Biol Chem. 2004 Oct 08; 279(41):42719-25.
Score: 0.028
-
DEC1 (STRA13) protein expression relates to hypoxia- inducible factor 1-alpha and carbonic anhydrase-9 overexpression in non-small cell lung cancer. J Pathol. 2003 Jun; 200(2):222-8.
Score: 0.026
-
HIF activation identifies early lesions in VHL kidneys: evidence for site-specific tumor suppressor function in the nephron. Cancer Cell. 2002 Jun; 1(5):459-68.
Score: 0.024
-
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999 May 20; 399(6733):271-5.
Score: 0.020
-
Regulation of gene expression by oxygen levels in mammalian cells. Adv Nephrol Necker Hosp. 1999; 29:191-206.
Score: 0.019
-
Analysis of gene expression in ductal carcinoma in situ of the breast. Clin Cancer Res. 2002 Dec; 8(12):3788-95.
Score: 0.006
-
Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer. Cancer Res. 2001 Nov 01; 61(21):7992-8.
Score: 0.006